ID
13880
Description
Brain Myelination Effects of Paliperidone Palmitate Versus Oral Risperidone in First Episode Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT01458379
Link
https://clinicaltrials.gov/show/NCT01458379
Keywords
Versions (1)
- 3/13/16 3/13/16 -
Uploaded on
March 13, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Schizophrenia NCT01458379
Eligibility Schizophrenia NCT01458379
- StudyEvent: Eligibility
Similar models
Eligibility Schizophrenia NCT01458379
- StudyEvent: Eligibility
C0036341 (UMLS CUI [1,2])
C0036337 (UMLS CUI [1,3])
C0011581 (UMLS CUI [1,4])
C0014544 (UMLS CUI [1,2])
C0018674 (UMLS CUI [2])
C0338614 (UMLS CUI [2])
C0023009 (UMLS CUI [2])
C0073393 (UMLS CUI [1,2])
C0753678 (UMLS CUI [1,3])
C2719626 (UMLS CUI [1,4])